announces fda clearance - Robuta Search

https://www.prnewswire.com/news-releases/acepodia-announces-fda-clearance-of-investigational-new-drug-application-for-ace1831-in-igg4-related-disease-302306506.html Acepodia Announces FDA Clearance of Investigational New Drug Application for ACE1831 in... Nov 15, 2024 - /PRNewswire/ -- Acepodia (6976:TT), a clinical-stage biotechnology company developing first-in-class cell therapies with its unique Antibody-Cell Conjugation... announces fda clearance investigational new acepodia drug application https://www.prnewswire.com/news-releases/acepodia-announces-fda-clearance-of-investigational-new-drug-application-for-ace2016-a-first-in-class-allogeneic-anti-egfr-cell-therapy-302052466.html Acepodia Announces FDA Clearance of Investigational New Drug Application for ACE2016, a... Feb 4, 2024 - /PRNewswire/ -- Acepodia (6976:TT), a clinical stage biotechnology company developing first-in-class cell therapies with its unique Antibody-Cell Conjugation... announces fda clearance investigational new acepodia drug application https://www.globenewswire.com/news-release/2025/10/14/3166144/0/en/Tr1X-Announces-FDA-Clearance-of-IND-Application-for-TRX319-a-First-in-Class-Allogeneic-CAR-Tr1-Treg-Cell-Therapy-for-Progressive-Multiple-Sclerosis-and-50-Million-in-Additional-Fin.html Tr1X Announces FDA Clearance of IND Application for TRX319, Oct 14, 2025 - Tr1X announced the FDA has cleared its IND application for TRX319 in progressive multiple sclerosis and a $50M financing that extends its runway into... announces fda clearance ind application https://www.prnewswire.com/news-releases/acepodia-announces-fda-clearance-of-ind-application-for-ace1831-an-anti-cd20-armed-allogeneic-gamma-delta-t-cell-therapy-candidate-to-treat-patients-with-non-hodgkins-lymphoma-301570711.html Acepodia Announces FDA Clearance of IND Application for ACE1831, an Anti-CD20 Armed Allogeneic... Jun 20, 2022 - /PRNewswire/ -- Acepodia, a clinical-stage biotechnology company developing first-in-class cell therapies with its unique Antibody-Cell Conjugation (ACC)... announces fda clearance acepodia ind application anti https://www.prnewswire.com/news-releases/tr1x-announces-fda-clearance-of-first-investigational-new-drug-application-for-trx103-an-allogeneic-regulatory-t-cell-therapy-to-treat-autoimmune-diseases-302112587.html Tr1X Announces FDA Clearance of First Investigational New Drug Application for TRX103, an... Apr 10, 2024 - /PRNewswire/ -- Tr1X, Inc., an autoimmune and inflammatory disease cell therapy company focused on the development of novel allogeneic regulatory T cell... announces fda clearance investigational new first drug application https://www.medtechdive.com/press-release/20260401-prana-surgical-announces-the-prana-systemtm-receives-fda-clearance-1/ Prana Surgical Announces the Prana System™ Receives FDA Clearance | MedTech Dive MedTech industry news receives fda clearance prana surgical announces medtech https://www.3dsystems.com/press-releases/3d-systems-announces-fda-510k-clearance-expanding-vspr-orthopedics-indications 3D Systems Announces FDA 510(k) Clearance Expanding VSP® Orthopedics Indications to Include... systems announces fda clearance expanding orthopedics https://www.neurologica.com/publications/press-releases/neurologica-announces-fda-510k-clearance-of-bodytom-64 NeuroLogica Announces FDA 510(k) Clearance of BodyTom® 64 Aug 9, 2023 - NeuroLogica announced that the BodyTom® 64 Point-of-Care Mobile Computed Tomography (CT) Scanner, has received 510(k) clearance from the U.S. FDA. announces fda clearance